Bydureon is a prescription medication used to improve blood sugar control in adults and children aged 10 years and older with type 2 diabetes. It is used in conjunction with diet and exercise and is administered as an injection once every seven days.
Bydureon is not recommended for use in pregnant women as it may cause thyroid tumours, including thyroid cancer. In animal studies, pregnant animals given Bydureon had babies born with problems. However, there have been no well-controlled studies in humans. Therefore, the potential risks and benefits of using Bydureon during pregnancy should be carefully considered and discussed with a doctor.
What You'll Learn
- Bydureon is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
- Bydureon is not recommended for patients with severe gastrointestinal disease
- Bydureon may cause acute pancreatitis
- Bydureon may cause acute kidney injury
- Bydureon may cause gallbladder disease
Bydureon is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2
Bydureon is a prescription medication that is used to improve blood sugar control in adults and children aged 10 and older with type 2 diabetes mellitus. It is not recommended as the first choice of medicine for treating diabetes.
Bydureon is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN 2). This is because Bydureon has been found to cause thyroid C-cell tumours in animal studies, and it is unknown whether it will cause these tumours in humans.
Medullary thyroid carcinoma is a type of thyroid cancer that originates in the thyroid gland's C-cells. It is a rare form of cancer that accounts for about 3% of all thyroid cancers. MTC is typically treated with surgery, radiation therapy, chemotherapy, or targeted therapy.
Multiple endocrine neoplasia type 2 (MEN 2) is a rare genetic disorder that affects the body's endocrine system, which includes the thyroid, parathyroid, and adrenal glands. People with MEN 2 are at an increased risk of developing tumours in these glands, as well as other endocrine-related conditions such as pheochromocytoma and carcinoid syndrome. MEN 2 is typically inherited as an autosomal dominant trait, meaning that a person only needs to inherit one copy of the altered gene to be affected.
Food Trucks: Safe Eating While Pregnant?
You may want to see also
Bydureon is not recommended for patients with severe gastrointestinal disease
Bydureon is a prescription medication that is used along with diet and exercise to treat type 2 diabetes. It is not recommended for use in patients with severe gastrointestinal disease, including gastroparesis. This is because Bydureon is commonly associated with gastrointestinal adverse reactions, including nausea, vomiting, and diarrhea. Therefore, the use of Bydureon in patients with severe gastrointestinal disease is not recommended as it may worsen their condition.
Bydureon comes in an injectable form to be given just under the skin (subcutaneous) once a week, at any time of day with or without meals. It is important to follow the doctor's instructions for taking Bydureon and to inform them of any pre-existing health conditions, including gastrointestinal problems.
Gas-X Softgels: Safe During Pregnancy?
You may want to see also
Bydureon may cause acute pancreatitis
Bydureon is a prescription medication used to improve blood sugar control in adults and children (aged 10 and older) with type 2 diabetes. It is a long-acting form of the medicine in Byetta (exenatide) and is administered as an injection once every seven days. Bydureon is not suitable for treating type 1 diabetes.
The risk of developing acute pancreatitis while taking Bydureon is increased if you have a history of pancreatitis. Therefore, it is important to inform your doctor if you have previously experienced pancreatitis before starting treatment with Bydureon. Additionally, Bydureon is not recommended for individuals with a history of pancreatitis, and alternative antidiabetic therapies should be considered.
It is worth noting that the occurrence of acute pancreatitis due to Bydureon is rare in clinical trials. However, post-marketing reports have indicated cases of acute pancreatitis, including hemorrhagic and necrotizing pancreatitis, which can sometimes result in death.
If you are taking Bydureon, it is crucial to be vigilant for any signs or symptoms of acute pancreatitis. In case of suspected pancreatitis, it is imperative to discontinue Bydureon promptly and seek appropriate medical management.
Lupini Beans: Safe Pregnancy Superfood?
You may want to see also
Bydureon may cause acute kidney injury
Bydureon is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is also contraindicated in patients with a history of drug-induced immune-mediated thrombocytopenia from exenatide products.
Bydureon is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated as an adjunct to diet and exercise to improve glycemic control in adults and pediatric patients aged 10 years and older with type 2 diabetes mellitus. It is not recommended as first-line therapy for patients inadequately controlled on diet and exercise. It should not be used to treat type 1 diabetes.
Bydureon is an extended-release formulation of exenatide. It should not be coadministered with other exenatide-containing products. It has not been studied in patients with a history of pancreatitis.
The most common side effects of Bydureon may include nausea, diarrhea, headache, vomiting, constipation, itching at the injection site, a small bump at the injection site, and indigestion.
Pregnancy and Milk of Magnesia: Understanding the Safety and Benefits
You may want to see also
Bydureon may cause gallbladder disease
Bydureon (exenatide) is a prescription medication used to improve blood sugar (glucose) control in adults and children aged 10 and above with type 2 diabetes mellitus. It is used in conjunction with diet and exercise and is administered as an injection once every seven days.
Bydureon has been associated with acute gallbladder disease, including cholelithiasis (gallstones) and cholecystitis (inflammation of the gallbladder). In clinical trials, 1.9% of patients treated with Bydureon reported an acute event of gallbladder disease, compared to 1.4% of patients treated with a placebo.
If you are taking Bydureon and suspect you have gallbladder disease, you should contact your doctor immediately for further clinical assessment and appropriate follow-up. Symptoms of gallbladder disease may include:
- Pain in the upper right or middle area of the abdomen
- Abdominal bloating or tenderness
- Nausea and vomiting
- Fever
- Yellowing of the skin or eyes
If you experience any of these symptoms, it is important to seek medical attention promptly.
Onion Tea During Pregnancy: Exploring Its Safety and Benefits
You may want to see also
Frequently asked questions
It is not known if Bydureon is safe during pregnancy. It is recommended that you consult your doctor before taking this medication.
It is not known if Bydureon is safe to take if you are trying to get pregnant. It is recommended that you consult your doctor before taking this medication.
It is not known if Bydureon is safe to take if you are breastfeeding. It is recommended that you consult your doctor before taking this medication.
Yes, Bydureon is used to treat type 2 diabetes. It is not recommended for treating type 1 diabetes.